Fundz

Envisagenics Appoints Sudhir Rao, M.S., MBA as Chief Business Officer to Strengthen Leadership Team

PRIVATEFeb 13, 2025

Position

Chief Business Officer

Company

Envisagenics

Sudhir Rao
New YorkBiotechnologyData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence

Description

Envisagenics has appointed Sudhir Rao, M.S., MBA as Chief Business Officer (CBO) to expand and strengthen its leadership team. Mr. Rao's extensive leadership in biopharma R&D, business development, alliance management, and strategy will drive Envisagenics' position as a leader in RNA splicing therapeutics and the overall growth of the company.

Quick answer

Envisagenics Appoints Sudhir Rao, M.S., MBA as Chief Business Officer to Strengthen Leadership Team (February 13, 2025). Envisagenics is based in New York, New York, United States.

Who is the new Chief Business Officer at Envisagenics?
Envisagenics named Sudhir Rao Chief Business Officer, announced February 13, 2025.
What did Envisagenics announce on February 13, 2025?
Envisagenics has appointed Sudhir Rao, M.S., MBA as Chief Business Officer (CBO) to expand and strengthen its leadership team. Mr. Rao's extensive leadership in biopharma R&D, business development, alliance management, and strategy will drive Envisagenics' position as a leader in RNA splicing therapeutics and the overall growth of the company.
What does Envisagenics do?
Envisagenics is an AI-driven biotechnology company harnessing the therapeutic potential of RNA splicing.
Where is Envisagenics based?
Envisagenics is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
Emmes (January 16, 2025), Cardurion Pharmaceuticals (January 8, 2025), Dataiku (February 5, 2025) and AIRS Medical (February 4, 2025) also announced leadership changes within 45 days of Envisagenics.

Source: Fundz verified event record.

Other recent leadership changes in Data And Analytics and Science And Engineering

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Envisagenics, and when

A new leader at Envisagenics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Envisagenics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Envisagenics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Envisagenics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Envisagenics

Location

New York, New York, United States

About

Envisagenics is an AI-driven biotechnology company harnessing the therapeutic potential of RNA splicing. Over 95% of human genes undergo alternative splicing, a process generating multiple RNA isoforms from a single gene. Alternative splicing holds the key to understanding and targeting over 370 diseases, including cancer and neurodegenerative disorders. SpliceCore boasts an impressive 400-fold increase in transcriptomic search space compared to conventional tools for target identification. Leveraging our extensive map of over 14 million RNA splicing events, SpliceCore enables the discovery of disease-specific targets, paving the way for the rational design and development of RNA therapeutics and immunotherapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Envisagenics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Envisagenics's next move

Learn about Strategic plan

Envisagenics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.